# Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/nivolumab-plus-ipilimumab-in-advanced-non-small-cell-lung-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Matthew D. Hellmann,Luis Paz‐Ares,Reyes Bernabe Caro,Bogdan Żurawski,Sang‐We Kim,Enric Carcereny,Keunchil Park,Aurelia Alexandru,Lorena Lupinacci,Emmanuel de la Mora Jimenez,Hiroshi Sakai,István Albert,A. Vergnenègre,Solange Peters,Konstantinos Syrigos,Fabrice Barlési,Martin Reck,Hossein Borghaei,Julie R. Brahmer,Kenneth J. O’Byrne,William J. Geese,Prabhu Bhagavatheeswaran,Sridhar K. Rabindran,Ravi S. Kasinathan,Faith E. Nathan,Suresh S. Ramalingam |
| Citations | 2,866 |
| DOI | 10.1056/nejmoa1910231 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1910231?articleTools=true |
| OpenAlex ID | https://openalex.org/W2976744492 |
| PMID | 31562796 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Matthew D. Hellmann](https://scholariq.org/researchers/matthew-d-hellmann/)
- [Julie R. Brahmer](https://scholariq.org/researchers/julie-r-brahmer/)
- [Keunchil Park](https://scholariq.org/researchers/keunchil-park/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.